"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Analysis of the results of intravesical perfusion therapy combined with immediate or non-immediate hematoporphyrin intravesical perfusion photodynamic therapy (PDT) after TURBT for NMIBC. This is an ...

A phase I study of ADXS-504, a cancer type specific immunotherapy, for patients with biochemically recurrent prostate cancer. Background: The therapeutic benefit of pelvic lymph node dissection (PLND) ...

Extended vs standard pelvic lymph node dissection does not improve oncologic outcomes in patients undergoing radical cystectomy for muscle-invasive urothelial carcinoma of the bladder. Patients ...

N1 Single lymph node metastasis, 2 cm or less in greatest dimension N1 Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node) N2 ...

March 11, 2010 —Systematic removal of pelvic as well as para-aortic lymph nodes may improve survival time vs pelvic lymphadenectomy alone in patients at medium to high risk for endometrial cancer ...

Preoperative (left; top and bottom) and postoperative PSMA-PET/CT images (right; top and bottom) demonstrate the successful removal of two positive pelvic lymph nodes in the radioguided surgical ...

No benefit was found in low-risk patients who underwent pelvic lymph node dissection (PLND). The extent of pelvic lymph node dissection (PLND) in patients undergoing radical prostatectomy (RP) for ...